These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 438974)

  • 1. Microencapsulation of bitolterol for controlled release and its effect on bronchodilator and heart rate activities in dogs.
    John PM; Minatoya H; Rosenberg FJ
    J Pharm Sci; 1979 Apr; 68(4):475-81. PubMed ID: 438974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
    Minatoya H
    J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative heart rate effects of oral administration of bitolterol, terbutaline and trimetoquinol in unanesthetized dogs.
    Nakanishi H; Nakahata N; Ito G; Yoshida H
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):185-8. PubMed ID: 6104851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of microencapsulated ion-exchange resin beads.
    Motycka S; Nairn JG
    J Pharm Sci; 1979 Feb; 68(2):211-5. PubMed ID: 423093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microencapsulation of theophylline using ethylcellulose: in vitro drug release and kinetic modelling.
    Lavasanifar A; Ghalandari R; Ataei Z; Zolfaghari ME; Mortazavi SA
    J Microencapsul; 1997; 14(1):91-100. PubMed ID: 8994078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulated hydrophilic polymer beads containing indomethacin as controlled release drug delivery systems.
    Suryakusuma H; Jun HW
    J Pharm Pharmacol; 1984 Aug; 36(8):497-501. PubMed ID: 6148389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethylcellulose molecular weight on the properties of theophylline microspheres.
    Dashevsky A; Zessin G
    J Microencapsul; 1997; 14(3):273-80. PubMed ID: 9147278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of various microencapsulation techniques: effect of polymer viscosity on microcapsule characteristics.
    Murtaza G; Ahamd M; Akhtar N; Rasool F
    Pak J Pharm Sci; 2009 Jul; 22(3):291-300. PubMed ID: 19553177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethylcellulose microparticles: a review.
    Murtaza G
    Acta Pol Pharm; 2012; 69(1):11-22. PubMed ID: 22574502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of drug-release from poly-disperse microencapsulated spherical particles.
    Sirotti C; Colombo I; Grassi M
    J Microencapsul; 2002; 19(5):603-14. PubMed ID: 12433303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects.
    Kass I; Mingo TS
    Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
    Cantor SL; Hoag SW; Augsburger LL
    Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
    Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
    Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
    Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
    J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(Alpha-(tert-butylamino)methyl)-5-hydroxy-m-xylene-alpha, alpha'-diol, a selective bronchodilator.
    Schwender CF; Sunday BR; Shavel J
    J Med Chem; 1974 Oct; 17(10):1112-5. PubMed ID: 4153860
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
    Constantine JW; McIlhenny HM; Moore PF
    J Pharmacol Exp Ther; 1979 Mar; 208(3):371-6. PubMed ID: 430357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some pharmacodynamic effects of eformoterol in the horse.
    Ladaga GJ; Lezica FP; Ferraro G; De Erausquin GA
    J Vet Pharmacol Ther; 2007 Oct; 30(5):496-9. PubMed ID: 17803747
    [No Abstract]   [Full Text] [Related]  

  • 20. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.